MedTrace Logo

The Effect of Calcitriol on Progress and Activity of Lupus Nephritis

NCT01863641 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2013-05-29

No results posted yet for this study

Summary

The purpose of this study is to determine whether calcitriol is effective in the treatment of lupus nephritis.

Conditions

Interventions

DRUG

calcitriol

Patients will receive calcitriol at a fixed dose of 0.25 µg (one oral pearl) daily.

DRUG

placebo

Patients will receive placebo similar to intervention (shape, color and design) 1 oral unit daily.

Sponsors & Collaborators

  • Guilan University of Medical Sciences

    lead OTHER

Principal Investigators

  • Banafsheh ghavidel parsa, MD · Guilan University of Medical Sciences, Iran

  • Alireza Amir Maafi, MD Student · Student Research Committee, Guilan University of Medical Sciences, Rasht, Iran

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-04-30
Primary Completion
2013-10-31
Completion
2014-04-30

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01863641 on ClinicalTrials.gov